Independent blinded validation of a novel blood-based early pancreatic cancer detection test. This is an ASCO Meeting Abstract from the 2024 ASCO Annual Meeting I. This abstract does not include a ...
Osimertinib plus anlotinib in patients with untreated, EGFR-mutated, advanced non-small-cell lung cancer with concurrent gene alterations: A single-arm, prospective, multicenter phase II study. Safety ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results